Two Different Cataract Surgical Procedures to Prevent Posterior Capsule Opacification
Effectiveness of Two Different Surgical Procedures to Prevent Posterior Capsule Opacification in Age-related Cataract Patients
1 other identifier
interventional
240
1 country
1
Brief Summary
In this study, the investigators introduce a new "capsule-reserved" cataract surgical procedure in which anterior lens capsule is reserved and attached onto posterior lens capsule in the purpose of preventing posterior capsule opacification (PCO). A prospective randomized controlled study is reported to compare the new "capsule-reserved" surgical procedure with conventional one on the effectiveness to prevent posterior capsule opacification in age-related cataract patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2015
CompletedFirst Submitted
Initial submission to the registry
May 4, 2015
CompletedFirst Posted
Study publicly available on registry
May 15, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2016
CompletedMay 3, 2016
April 1, 2016
1.3 years
May 4, 2015
April 29, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Change from Baseline in posterior capsule opacification grading score
Posterior capsule opacification(PCO)was recorded by standardized slit lamp retroillumination images and analyzed using the EPCO2000 program. The severity of PCO was clinically graded from 0 (none) to 4 (severe)
post-operative day 1, post-operative week 1, post-operative month 1, post-operative month 3,
Secondary Outcomes (2)
Change from Baseline in central posterior capsule thickness
post-operative day 1, post-operative week 1, post-operative month 1, post-operative month 3, post-operative month 6, post-operative year 1
Change from Baseline in central posterior capsule density
post-operative day 1, post-operative week 1, post-operative month 1, post-operative month 3, post-operative month 6, post-operative year 1
Other Outcomes (2)
Change from Baseline in best corrected visual acuity
post-operative day 1, post-operative week 1, post-operative month 1, post-operative month 3, post-operative month 6, post-operative year 1
Change from Baseline in contrast sensitivity
post-operative day 1, post-operative week 1, post-operative month 1, post-operative month 3, post-operative month 6, post-operative year 1
Study Arms (2)
Capsule-reserved surgical procedure
EXPERIMENTALIn this group, the anterior lens capsule was reserved after continuous curvilinear capsulorhexis. The reserved anterior capsule was pressed flattened by the optical surface of the IOL and attached onto the posterior lens capsule. Phacoemulsification was performed with the same device and handpieces, using the same phaco chop technique as in the conventional procedure group.
Conventional surgical procedure
NO INTERVENTIONIn this group, the anterior lens capsule was not reserved or attached onto the posterior lens capsule.
Interventions
The anterior lens capsule was reserved after continuous curvilinear capsulorhexis. The reserved anterior capsule was pressed flattened by the optical surface of the IOL and attached onto the posterior lens capsule.
Eligibility Criteria
You may qualify if:
- Aged 50 years or above
- Both eyes were diagnosed with age-related cataract
- Both eyes were planed to undergo the "Phacoemulsification and IOL implantation" surgery with 1 month
- Biocular BCVA improvement post surgery was feasible judged by the ophthalmologists.
You may not qualify if:
- Other ocular diseases
- ACD\<3CT
- Combined cataract surgery (trabeculoplasty, keratoplasty)
- Lens pseudoexfoliation syndrome combined with glaucoma or zonular abnormalities
- Previous intraocular surgery or trauma (laser not included)
- Uveitis
- Recent ocular infection
- Proliferative diabetic retinopathy
- Diabetes mellitus
- Congenital ocular abnormalities (aniridia, congenital cataract)
- Atrophy of iris
- Participants with previous clinical trials 30 days before surgery
- Using prostanoid eye drops
- Uncontrolled systematic diseases
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Zhognshan Ophthalmic Center, Sun Yat-sen University
Guangzhou, Guangdong, 510060, China
Related Publications (4)
Luo L, Lin H, Chen W, Qu B, Zhang X, Lin Z, Chen J, Liu Y. Intraocular lens-shell technique: adjustment of the surgical procedure leads to greater safety when treating dense nuclear cataracts. PLoS One. 2014 Nov 17;9(11):e112663. doi: 10.1371/journal.pone.0112663. eCollection 2014.
PMID: 25401512BACKGROUNDLin H, Yan P, Yu K, Luo L, Chen J, Lin Z, Chen W. Anterior segment variations after posterior chamber phakic intraocular lens implantation in myopic eyes. J Cataract Refract Surg. 2013 May;39(5):730-8. doi: 10.1016/j.jcrs.2012.12.026. Epub 2013 Mar 14.
PMID: 23499067BACKGROUNDLin HT, Chen WR, Ding ZF, Chen W, Wu CR. Clinical evaluation of two multifocal intraocular lens implantation patterns. Int J Ophthalmol. 2012;5(1):76-83. doi: 10.3980/j.issn.2222-3959.2012.01.16. Epub 2012 Feb 18.
PMID: 22553760BACKGROUNDLuo L, Lin H, He M, Congdon N, Yang Y, Liu Y. Clinical evaluation of three incision size-dependent phacoemulsification systems. Am J Ophthalmol. 2012 May;153(5):831-839.e2. doi: 10.1016/j.ajo.2011.10.034. Epub 2012 Feb 4.
PMID: 22310081RESULT
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yizhi Liu, M.D., PhD
Zhongshan Ophthalmic Center, Sun Yat-sen University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
May 4, 2015
First Posted
May 15, 2015
Study Start
May 1, 2015
Primary Completion
August 1, 2016
Study Completion
August 1, 2016
Last Updated
May 3, 2016
Record last verified: 2016-04